Connect with us

Health

International researchers set out to compare different countries’ COVID-19 responses – News-Medical.Net

The typical measures of the efficacy of a country’s response to COVID-19 are the contagion curve and the number of deaths from the disease.

Published

on

ADVERTISEMENT

Reviewed by Emily Henderson, B.Sc.Sep 17 2020
The typical measures of the efficacy of a country’s response to COVID-19 are the contagion curve and the number of deaths from the disease. Indeed, the frequently expressed aim of “flattening the curve” refers to a perceived need to slow the rate of transmission so that healthcare systems are not overwhelmed. An international group of researchers have set out to go beyond these indicators by discussing how and why the strategies implemented by count…

Click here to view the original article.

Health

NSW records no new community transmission for third consecutive day – 9News

New South Wales has recorded no new locally transmitted cases of COVID-19 in NSW for third day in row.

Published

on

ADVERTISEMENT

Auto News: Beat the price rises: currency pressure poised to push up the cost of cars in 2020 – caradvice.com.au

Click here to view the original article.

Continue Reading

Health

MS lifeline as drug that can slow disease listed – Chinchilla News

Patients who develop the second progressive stage of Multiple Sclerosis will only have to pay $41 for a drug that helps slow down the disease.

Published

on

post featured image
ADVERTISEMENT

Patients living with multiple sclerosis have been granted a lifeline with the federal government listing a drug that can help slow down the progression of the disease.
The move will mean all patients who might benefit from “Mayzent” will only have to pay $41 per script rather than the estimated $25,000 yearly cost.
Multiple sclerosis, known as MS, is the most commonly acquired neurological disease in younger adults with more than 25,600 Australians living with the condition.
The average age of diagnosis…

Click here to view the original article.

Continue Reading

Health

Rush for results could lead to inferior Covid vaccine, say scientists – The Guardian

Push to roll out injections may see elderly miss out on effective coronavirus inoculations

Published

on

ADVERTISEMENT

Scientists have warned that early adoption of a Covid vaccine with only moderate effectiveness could disrupt efforts to test and create improved versions. Immunising against the disease is not going to be a simple business of turning off the virus once the first vaccine appears, they say. In fact, there could be considerable confusion as researchers struggle to pinpoint the best versions for different vulnerable groups, such as the elderly.
The vaccines coming through fastest are the most experimental….

Click here to view the original article.

Continue Reading

Trending

You might also like ...

post featured image
Victoria disappoints, doubts over vaccine – Tenterfield Star
How Corona Pandemic will impact Breast Cancer Predictive Genetic Testing market and what change Development Strategy 2020-25 – TechnoWeekly
post featured image
Long COVID Syndrome: Study Points Risk Factors, Treatment and How to… – AlKhaleej Today